ABLE Member Strand Life Sciences presented insights from its COVID19 genomic surveillance initiative of sequencing 12,800 SARS-CoV-2 samples from the city of Bengaluru on Sunday, 17th July, 2022, as a part of the “Celebrating Covid Genomic Sequencing and Surveillance effort in Karnataka event at Sir Puttanna Chetty Townhall, JC Road, Bengaluru.

The event was presided over by Dr Ashwath Narayan CN, Minister of Higher Education, IT & BT, Govt of Karnataka, Dr. Thrilok Chandra IAS, Special Health Commissioner, BBMP, Dr. Ramesh Hariharan, CEO & Co-Founder, Strand Life Sciences, , Prof. Rajesh Sundaresan, IISc, Professor, Dr Vishal US Rao, Member of Genomic Surveillance Committee, Karnataka, and Director - Head and Neck Oncology, HCG Cancer Hospital, and Prof. Rakesh Mishra, Director, Tata Institute for Genetics and Society. RTPCR +ve samples were collected between July, 2021 and June, 2022 from various laboratories in Bengaluru, Karnataka, with due permissions from BBMP.

Source: Healthworld from The Economic Times

ABLE Member Strand Life Sciences presented insights from its COVID19 genomic surveillance initiative of sequencing 12,800 SARS-CoV-2 samples